Myocarditis Tops List of Covid “Vaccine” Injuries Among 12- to 17-Year-Olds, VAERS Data Show

The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,033,994 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Jan. 1, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.

The data included a total of 21,745 reports of deaths — an increase of 363 over the previous week — and 170,446 reports of serious injuries, including deaths, during the same time period — up 3,840 compared with the previous week.

Excluding “foreign reports” to VAERS, 723,042 adverse events, including 9,936 deaths and 64,406 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Jan. 7, 2021.

Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 9,936 U.S. deaths reported as of Jan. 7, 19% occurred within 24 hours of vaccination, 24% occurred within 48 hours of vaccination and 61% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S., 516 million COVID vaccine doses had been administered as of Jan. 7, including 303 million doses of Pfizer, 197 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).

Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.

U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2021, for 5- to 11-year-olds show:

The most recent death involves a 7-year-old girl (VAERS I.D. 1975356) from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.

• 14 reports of myocarditis and pericarditis (heart inflammation).
• 22 reports of blood clotting disorders.

U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2021, for 12- to 17-year-olds show:  

The most recent death involves a 15-year-old girl from Minnesota (VAERS I.D. 1974744), who died 177 days after receiving her second dose of Pfizer from a pulmonary embolus. An autopsy is pending.

• 62 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases
  attributed to Pfizer’s vaccine.
• 589 reports of myocarditis and pericarditis with 578 cases attributed to Pfizer’s vaccine.
• 149 reports of blood clotting disorders, with all cases attributed to Pfizer.

U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2021, for all age groups combined, show:

• 19% of deaths were related to cardiac disorders.
• 55% of those who died were male, 42% were female and the remaining death reports did not include the gender of the deceased.
• The average age of death was 72.6.
• As of Jan. 7, 4,806 pregnant women reported adverse events related to COVID vaccines, including 1,533 reports of miscarriage or premature birth.
• Of the 3,419 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 41% to Moderna and 8% to J&J.
• 836 reports of Guillain-Barré syndrome (GBS), with 41% of cases attributed to Pfizer, 30% to Moderna and 28% to J&J.
• 2,256 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
• 12,331 reports of blood clotting disorders in the U.S. Of those, 5,457 reports were attributed to Pfizer, 4,398 reports to Moderna and 2,428 reports to J&J.
• 3,688 cases of myocarditis and pericarditis with 2,269 cases attributed to Pfizer, 1,249 cases to Moderna and 158 cases to J&J’s COVID vaccine.